Carvajal Alegria, G., Cornec, D. Y. K., Renaudineau, Y., Saraux, A., & Devauchelle-Pensec, V. (2021). Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade. Rheumatol Ther.
Čikaški stil citiranjaCarvajal Alegria, Guillermo, Divi Y. K. Cornec, Yves Renaudineau, Alain Saraux, i Valérie Devauchelle-Pensec. "Inflammatory Markers Are Quickly Improved By Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade." Rheumatol Ther 2021.
MLA način citiranjaCarvajal Alegria, Guillermo, et al. "Inflammatory Markers Are Quickly Improved By Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade." Rheumatol Ther 2021.